Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Xencor, Inc.
Xencor, Inc.
University Hospital, Clermont-Ferrand
Context Therapeutics Inc.
Indiana University
BioNTech SE
Loma Linda University
City of Hope Medical Center
University Medical Center Groningen
West China Hospital
University of Arizona
Jonsson Comprehensive Cancer Center
Western University, Canada
Columbia University
University of California, Irvine
University Health Network, Toronto
Centre Leon Berard
Fudan University
University Medical Center Groningen
Second Affiliated Hospital of Guangzhou Medical University
Royal Marsden NHS Foundation Trust
Dana-Farber Cancer Institute